Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials

References

• Ai X, Yu P, Peng L, Luo L, Liu J, Li S, Lai X, Luan F, Meng X. 2021. Berberine: a review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases. Front Pharmacol. 12:762654. doi:10.3389/fphar.2021.762654.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, et al. 2018. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 72(14):e91–e220. doi:10.1016/j.jacc.2017.10.054.
   PubMed Web of Science ®Google Scholar
• Amjad W, Qureshi W, Farooq A, Sohail U, Khatoon S, Pervaiz S, Narra P, Hasan SM, Ali F, Ullah A, et al. 2017. Gastrointestinal side effects of antiarrhythmic medications: a review of current literature. Cureus. 9(9):e1646. doi:10.7759/cureus.1646.
   PubMedGoogle Scholar
• An N, Zhang G, Li Y, Yuan C, Yang F, Zhang L, Gao Y, Xing Y. 2022. Promising antioxidative effect of berberine in cardiovascular diseases. Front Pharmacol. 13:865353. doi:10.3389/fphar.2022.865353.
   PubMed Web of Science ®Google Scholar
• Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, et al. 2009. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 64(5):669–677. doi:10.1111/j.1398-9995.2009.01973.x.
   PubMed Web of Science ®Google Scholar
• Cai Y, Xin Q, Lu J, Miao Y, Lin Q, Cong W, Chen K. 2021. A new therapeutic candidate for cardiovascular diseases: berberine. Front Pharmacol. 12:631100. doi:10.3389/fphar.2021.631100.
   PubMed Web of Science ®Google Scholar
• Cao K, Chen K, Chen M, Hong K, Hua W, Huang C, Huang D, Jiang H, Li X, Li Y, et al. 2020. [2020 Chinese expert consensus on ventricular arrhythmias (an upgrade of 2016 consensus)]. Chin J Cardiac Pacing Electrophysiol. 34:189–253. (in Chinese).
   Google Scholar
• Cao K, Chen K, Chen M, Hong K, Hua W, Huang C, Huang D, Su X, Su Y, Tang B, et al. 2022. [ Chinese expert consensus on ventricular arrhythmias (primary edition)]. J Practical Electrocardiol. 31:77–98. (in Chinese).
   Google Scholar
• Chen M, Li Z, Fan Q, Cai Q, Yang X, Gu Y, Guo S, Lin R, Zhao C. 2022. [Research progress on pharmacological action and related mechanism of berberine]. Chinese Trad Herbal Drugs. 53:5861–5872. (in Chinese).
   Google Scholar
• Diao J, Zou Q. 1999. [Effectiveness of berberine for treating elderly with frequent premature ventricular contractions]. Chinas Naturopathy. 1999(07):32. (in Chinese).
   Google Scholar
• Fan G, Lu Z, Zhao D. 2004. [Clinic observation of berberine combined with propafenone for premature ventricular contractions]. The Medical Forum. 2004(02):125–126. (in Chinese).
   Google Scholar
• Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, Šmejkal K, Malaník M, et al. 2019. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 9(7):1923–1951. doi:10.7150/thno.30787.
   PubMed Web of Science ®Google Scholar
• Furuya-Kanamori L, Barendregt JJ, Doi SAR. 2018. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 16(4):195–203. doi:10.1097/XEB.0000000000000141.
   PubMed Web of Science ®Google Scholar
• Gorenek B, Fisher JD, Kudaiberdieva G, Baranchuk A, Burri H, Campbell KB, Chung MK, Enriquez A, Heidbuchel H, Kutyifa V, et al. 2020. Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice: a state-of-the-art review by the American College of Cardiology Electrophysiology Council. J Interv Card Electrophysiol. 57(1):5–26. doi:10.1007/s10840-019-00655-3.
   PubMed Web of Science ®Google Scholar
• Guo H. 2015. [Systematic review of the effect of oral berberine on premature ventricular contractions]. Clinical Med. 35:15–19. (in Chinese).
   Google Scholar
• Habtemariam S. 2020. Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacol Res. 155:104722. doi:10.1016/j.phrs.2020.104722.
   PubMed Web of Science ®Google Scholar
• Higgins J, Thomas J. 2021. Cochrane handbook for systematic reviews of interventions version 6.2. Cochrane Training. [accessed 2022 May 28]. https://training.cochrane.org/handbook/archive/v6.2.
   Google Scholar
• Hu Q, Hu X. 2006. [Efficacy of berberine for functional premature ventricular contractions: observation of 42 cases]. J Pract Trad Chin Med. 2006(02):73. (in Chinese).
   Google Scholar
• Klewer J, Springer J, Morshedzadeh J. 2022. Premature ventricular contractions (PVCs): a narrative review. Am J Med. 135(11):1300–1305. doi:10.1016/j.amjmed.2022.07.004.
   PubMed Web of Science ®Google Scholar
• Li X, Li S. 1993. [Observation of effectiveness of mexiletinc combined with berberine for treating refractory premature ventricular contractions]. J Jinzhou Med Univ. 1993(2):57–58. (in Chinese).
   Google Scholar
• Lin Q, Li P, Wu H, Peng W, Zhong H, Su W, Cheng C, Wang Y. 2022. [Advances in cardiovascular pharmacological activity of berberine hydrochloride]. J Pharm Res. 41:117–121. (in Chinese).
   Google Scholar
• Marcus GM. 2020. Evaluation and management of premature ventricular complexes. Circulation. 141(17):1404–1418. doi:10.1161/CIRCULATIONAHA.119.042434.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71. doi:10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Qiao M, Tan C, Lei C, Lu C. 2023. Effectiveness and safety of berberine for patients with premature ventricular contraction (PVC). PROSPERO 2023 CRD42023388337. [accessed 2023 Jan 14]. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=388337.
   Google Scholar
• Rao Z, Yu X. 2010. [An observation of oral berberine on 36 children with ventricular premature beats]. J Ped Pharm. 16(1):29–30. (in Chinese).
   Google Scholar
• Shao C, Wang W, Fu Y. 2009. [The clinical observation of berberine for the treatment of the patients with ventricular premature beat]. China Prac Med. 4:44–45. (in Chinese).
   Google Scholar
• Shen W, Liu S. 1994. [Effectiveness of berberine for treating premature ventricular contractions]. J Med Inform (Yunnan). 1994(4):5–6. (in Chinese).
   Google Scholar
• Society of Cardiac Pacing and Electrophysiology, Chinese Society of Biomedical Engineering. 2003. [Recommendations for diagnosis and treatment of premature ventricular contractions in children]. Modern Pract Med. 9(15):596. (in Chinese).
   Google Scholar
• Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, et al. 2019. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 366:l4898. doi:10.1136/bmj.l4898.
   PubMed Web of Science ®Google Scholar
• Su H, Chen L, Xi Q. 2010. [Clinic observation of berberine for functional premature ventricular contractions]. Med Inform. 5:3306–3307.
   Google Scholar
• Wang K, Feng X, Chai L, Cao S, Qiu F. 2017. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 49(2):139–157. doi:10.1080/03602532.2017.1306544.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zeng Y, Fu Y. 2003. [Comparative of effectiveness of berberine vs. mexiletinc for premature ventricular contractions]. Modern J Integ Trad Chinese Western Med. 2003(03):186. (in Chinese).
   Google Scholar
• Xu H, Liu C, Huang C, Chen L, Zheng Y, Huang S, Long X. 2019. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge. Colloids Surf B Biointerfaces. 181:927–934. doi:10.1016/j.colsurfb.2019.06.006.
   PubMed Web of Science ®Google Scholar
• Yang S, Tong Q. 2016. [Research progress of berberine in cardiovascular diseases]. Chin J Gerontol. 36:1526–1527. (in Chinese).
   Google Scholar
• Zamani M, Zarei M, Nikbaf-Shandiz M, Hosseini S, Shiraseb F, Asbaghi O. 2022. The effects of berberine supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis. Front Nutr. 9:1013055. doi:10.3389/fnut.2022.1013055.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang J, Gao S, Zhang Q, Wang B, Zhao Y. 2021. [Research progress of traditional Chinese medicine on ventricular premature contraction]. J Emerg Trad Chin Med. 30:2060–2064. (in Chinese).
   Google Scholar
• Zhao Z, Zhao S, Liu Z. 2000. [Analysis of 90 cases of simple frequent premature ventricular contractions]. Modern J Integr Trad Chin West Med. 2000(10):899–900. (in Chinese).
   Google Scholar
• Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, et al. 2006. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 8:746–837.
   PubMed Web of Science ®Google Scholar